Every CPG brand has some version of a label approval process. In practice, for most brands, it looks like this: design finalizes a label, someone on the regulatory or legal team reviews it, comments come back in an email or a shared document, revisions are made, and the label is approved. It's a reasonable workflow — and it fails in predictable ways.
It fails when the timeline is tight and the regulatory review is compressed. It fails when marketing copy changes after the regulatory review but before print. It fails when the formulation that the label was reviewed against is not the formulation that went into production. It fails when the same claim appears on the website and the social channels without ever going through the review process at all.
A functional label approval process doesn't just involve regulatory professionals. It integrates regulatory review into how all the other teams — formulators, designers, marketers, operations — do their work.
Stage 1: Claim Review at the Brief Stage
The most expensive point in a label approval process is the end: when a label file is complete, the design is final, and the retail buyer is waiting. That's also, in most organizations, when regulatory review happens.
The right intervention point is earlier — at the brief stage, when claims are being drafted and before a designer has turned them into label copy. A structure/function claim that gets flagged as a potential disease claim at the brief stage costs almost nothing to fix. The same flag at the print-ready stage costs a redesign, a revised brief, and typically a launch delay.
What this requires operationally: a channel through which marketing and brand teams can submit proposed claims for review before they go into design. A simple intake form, a Slack workflow, a claims management tool — the format matters less than the habit of routing claims before they're embedded in creative assets.
The regulatory check at this stage: does the claim meet the applicable threshold? Is it a structure/function claim or does it cross into disease claim territory? Does it need a disclaimer or qualifying language? These are answerable questions at the brief stage. They're more expensive to answer at the design stage.
Stage 2: Formulation and Ingredient Review
Label compliance review can't happen independently of formulation review. The label is a legal representation of what's in the product. If the formulation has changed since the last label review — a new ingredient source, a revised flavor system, a different mineral blend — the label may be wrong without anyone in the approval chain knowing it.
A functional label approval process treats formulation changes as triggers for label review, not just quality events.
The specific things that should trigger a label review when they change:
Ingredient or sub-ingredient change: Any new ingredient, or a supplier-side reformulation of an existing ingredient, needs to be reviewed for allergen implications, nutrient level changes that could affect a nutrient content claim, and any ingredient with a specific regulatory status (novel ingredients, ingredients with use restrictions, botanical ingredients).
Contract manufacturer or co-packer change: A new manufacturing facility means a new set of allergen co-packing risks, new equipment, and new cleaning protocols. If the facility runs other allergen-containing products on shared equipment, the advisory language on the label may need to be updated.
Formula optimization or cost reduction: When a formulation is adjusted for cost — changing the concentration of a fortifying ingredient, substituting a commodity ingredient — the nutrient levels that support the label's nutrient content claims may change. A product that qualified for "high protein" at 20g per serving may not qualify after a protein concentration adjustment.
Stage 3: Label Review Against Current Formulation
The formal label review — the one most brands already do — should verify the label against the current, production-ready formulation, not against a previous version or a planned formulation that hasn't been finalized.
The review should cover:
Required elements: Statement of identity, net quantity, Nutrition Facts panel, ingredient list, allergen declaration, name and place of business. Each should be verified as present and accurate — not just assumed to be correct from a prior review.
Nutrient content claims: Every claim verified against the current nutrition data. "High protein" requires ≥20% DV. "Low sodium" requires ≤140mg per serving. "Good source of fiber" requires 10–19% DV. The thresholds don't change; the nutrition data does.
Allergen declaration: Reviewed against the full formulation, including sub-ingredients in all compound ingredients and flavor systems. Not just reviewed against what appeared on the last label version.
Serving size: Confirmed against the RACC for the product's food category under 21 CFR 101.12. Serving sizes cannot be set below the RACC to make nutrition numbers look more favorable.
All claims, all channels: Not just the physical label — the website product page, the Amazon listing, the DTC email, and the marketing materials should all be reviewed at the same time. A disease claim on a product detail page creates the same regulatory exposure as a disease claim on the package.
Stage 4: Approval and Records
The approval stage is where most processes have their biggest gap. A label gets approved in an email chain. Six months later, the product is recalled and the brand needs to demonstrate that it had a review process. The email chain exists, but there's no structured record of what was reviewed, against what regulatory standard, with what supporting data, by whom, and when.
An approval record should include:
The label version reviewed (file name, version number, or hash)
The formulation version reviewed (spec sheet version, production record reference)
What was checked (required elements, specific claims, allergen review)
The regulatory standard applied to each check
The reviewer and the date
Any conditions on the approval (claims that need to be verified after production data is available, advisory language that should be added in the next revision)
This documentation doesn't need to be elaborate. It does need to be queryable. When a question comes from a retailer or a regulator about a specific label, the answer should be findable in minutes, not reconstructed from email threads.
Stage 5: Post-Launch Monitoring
Label compliance isn't a one-time event. Regulations change. The "healthy" claim definition changed in February 2025. Sesame was added to the allergen list in 2023. A product that was compliant at launch may not be compliant today.
Post-launch monitoring means reviewing existing labels when a relevant regulatory change occurs — identifying which products carry a claim or ingredient that's now subject to different requirements. Without a system of record for claims and formulations, that review requires manually checking every label. With a claims library and formulation database, it's a query.
Marketing copy and social monitoring should run continuously, not just at launch. Influencer content and affiliate posts create compliance exposure on an ongoing basis. FDA and FTC enforcement looks at the full scope of a brand's claims across every channel — not just what was approved at the time of label design.
What a Functional Process Looks Like
The brands that avoid recalls and warning letters have a few things in common:
Claims are reviewed at the brief stage, not just at the label review stage
Formulation changes trigger compliance reviews automatically
Every claim has a regulatory basis documented before it goes on a label
Marketing copy is reviewed with the same rigor as label copy
Approvals are documented in a system, not in email threads
None of this requires a large regulatory team. It requires a process with clear touchpoints and a system that connects the people doing the reviewing to the current state of the formulation and claims.
Build the Process Before You Need It
A label approval process that only activates when something goes wrong isn't a compliance process — it's incident response. The goal is a workflow that's built into how every team operates, so violations get caught at the cheapest possible point.
Truli's AI compliance platform integrates into the label approval workflow — automating the regulatory checks, maintaining a claims library with full review history, and monitoring marketing channels and social content after launch. Every finding includes the CFR reference and suggested fix. Book a demo to see how Truli fits into your label approval process.
